Jason A. Leverone, CFO of OnKure Therapeutics OKUR, has filed 0 purchases and 8 sales on the open market. Over the past 12 months that comes to a net sale of $4,381. The latest trade was on 09/21.

Jason A. Leverone

CFO

Company

OnKure Therapeutics OKUR

First filing

24/10/08

Trades

14 trades

Buys / sales

0 / 8

12-month net buying

−$4,381

Last trade

09/21

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
OnKure TherapeuticsOKUR	Open-market sale	09/21	09/23	302 sh	$2.97	$898.21	−1.6%
OnKure TherapeuticsOKUR	Open-market sale	06/22	06/24	303 sh	$4.40	$1,333.2	−1.6%
OnKure TherapeuticsOKUR	Open-market sale	03/23	03/24	301 sh	$4.16	$1,252.16	−1.8%
OnKure TherapeuticsOKUR	Open-market sale	25/12/22	25/12/23	302 sh	$2.97	$896.94	−1.8%
OnKure TherapeuticsOKUR	Open-market sale	25/09/22	25/09/24	303 sh	$2.62	$793.86	−2.3%
OnKure TherapeuticsOKUR	Open-market sale	25/06/23	25/06/25	303 sh	$2.38	$721.14	−2.3%
OnKure TherapeuticsOKUR	Open-market sale	25/04/04–25/04/07	25/04/08	3,122 sh2 trades	$2.94avg.	$9,179.22	−19.1%